Vitamin D receptor polymorphisms and lethal prostate cancer

Journal of Urology

Volumn 160, Issue 4, 1998, Pages 1405-1409

  Kibel, Adam S ^a   Isaacs, Sarah D ^a   Isaacs, William B ^a   Bova, G Steven ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Calcitriol; Disease susceptibility; Polymorphism (genetics); Prostatic neoplasms; Receptors; Risk factors

Indexed keywords

CALCITRIOL; VITAMIN D RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENETIC RISK; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0032323522     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62550-3     Document Type: Article

References (20)

1. Landis, S. H., Murray, T., Bolden, S. and Wingo, P. A.: Cancer statistics, 1998. Cancer J. Clin., 48: 6, 1998.
2. Mettlin, C. J., Murphy, G. P., Ho, R. and Menck, H. R.: The National Cancer Data Base report on longitudinal observations on prostate cancer. Cancer, 77: 2162, 1996.
3. Carter, B. S., Bova, G. S., Beaty, T. H., Steinberg, G. D., Childs, B., Isaacs, W. B. and Walsh, P. C.: Hereditary prostate cancer: epidemiologic and clinical features. J. Urol., 150: 797, 1993.
4. Morton, R. A., Jr.: Racial differences in adenocarcinoma of the prostate in North American men. Urology, 44: 637, 1994.
5. Haas, G. P. and Sakr, M. D.: Epidemiology of prostate cancer. Cancer J. Clin., 47: 273, 1997.
6. Schwartz, G. G. and Hylka, B. S.: Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis) Anticancer Res., 10: 1307, 1990.
7. Clemens, T. L., Adams, J. S., Henderson, S. L. and Holick, M. F.: Increased skin pigment reduces the capacity of the skin to synthesise vitamin D3. Lancet, 1: 74, 1982.
8. Orwoll, E. S. and Meier, D. E.: Alterations in calcium, vitamin D, and parathyroid hormone physiology in normal men with aging: relationship to development of senile osteopenia. J. Clin. Endocr. Metab., 63: 1262, 1986.
9. Hanchette, C. L. and Schwartz, G. G.: Geographic patterns of prostate cancer mortality: evidence for a protective effect of ultraviolet radiation. Cancer, 70: 2861, 1992.
10. Skowronski, R. J., Peehl, D. M. and Feldman, D.: Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines. Endocrinology, 132: 1952, 1993.
11. Hedlund, T. E., Moffatt, K. A. and Miller, G. J.: Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: evidence that the antiproliferative effects of 1 alpha,25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway. Endocrinology, 137: 1554, 1996.
12. Corder, E. H., Guess, H. A., Hulka, B. S., Friedman, G. D., Sadler M., Vollmer, R. T., Lobaugh, B., Drezner, M. K., Vogelman, J. H. and Orenteich, N.: Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol. Biomarkers Prev., 2: 467, 1993.
13. Morrison, N. A., Qi, J. C., Tokita, A., Kelly, P. J., Crofts, L., Nguyen, T. V., Sambrook, P. N. and Eisman, J. A.: Prediction of bone density from vitamin D receptor alleles. Nature, 367: 284, 1994.
14. Taylor, J. A., Hirvonen, A., Watson, M., Pittman, G., Mohler, J. L. and Bell, D. A.: Association of prostate cancer with vitamin D receptor gene polymorphisms. Cancer Res., 56: 4108, 1996.
15. Ingles, S. A., Ross, R. K., Yu, M. C., Irvine, R. A., La Pera, G., Haile, R. W. and Coetzee, G. A.: Association of prostate cancer risk with genetic polymorphisms in the vitamin D receptor and androgen receptor. J. Natl. Cancer Inst., 89: 166, 1997.
16. Riggs, B. L., Nguyen, T. B., Melton, L. J., III, Morrison, N. A., O'Fallon, W. M., Kelly, P. J., Egan, K. S., Sambrook, P. N., Muhs, J. M. and Eisman, J. A.: The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women. J. Bone Miner. Res., 10: 991, 1995.
17. Buttyan, R. S., Sawczuk, I. S., Benson, M. C., Seigal, J. D. and Olsson, C. A.: Enhanced expression of the c-myc protooncogene in high-grade human prostate cancers. Prostate, 11: 327, 1987.
18. Reitsma, P. H., Rothberg, P. G., Astrin, S. M., Trial J., Bar-Shairt, Z., Hall, A., Teitelbaum, S. L. and Kahn, A. J.: Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite. Nature, 306: 492, 1983.
19. Morrison, N. A., Yeoman, R., Kelly, P. J. and Eisman, J. A.: Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphisms and circulating osteocalcin. Proc. Natl. Acad. Sci., USA, 89: 6665, 1992
20. Zhuang, S. H., Schwartz, G. G., Cameron, D. and Burnstein, K. L.: Vitamin D receptor content and transcriptional activity do not fully predict antiproliferative effects of vitamin D in human prostate cancer cell lines. Molecular Cellular Endocr., 126: 83, 1997.